◀ Back to ARG1

ARG1 — F12

Text-mined interactions from Literome

Persson et al., J Exp Med 2000 (Lung Diseases...) : These pulmonary lesions were prevented when the infected animals were treated with H-D-Pro-Phe-Arg-chloromethylketone , an inhibitor of coagulation factor XII and plasma kallikrein, suggesting that inhibition of contact system activation could be used therapeutically in severe infectious disease
Hillmayer et al., Journal of thrombosis and haemostasis : JTH 2008 : Arg ( 227 ), Ser ( 249 ), Ser ( 251 ), and Tyr ( 260 ) are involved in the binding of MA-RT30D8 and MA-RT82F12 with rat TAFI ( a )
Scott et al., Blood 1987 : We also investigated the effect of Arg15-aprotinin on tissue kallikrein, plasmin, factor XIIa , factor XIa, and thrombin and found that the Ki slightly decreased from 5.1 X 10 ( -7 ) mol/L to 1.2 X 10 ( -7 ) mol/L for tissue kallikrein and slightly decreased from 2 X 10 ( -8 ) mol/L to 1 X 10 ( -8 ) mol/L for plasmin ... Arg15-aprotinin did not inhibit thrombin or factor XIIa , even though both enzymes are arginine directed serine proteases